To improve access to care, many professional organizations have advocated for classifying obesity as a disease. However, the ...

And fourth, focus on changing the environment, not just people. We must shift the focus to the systems and structures that ...

For many people, weight loss is often framed as a matter of willpower – a simple equation of exercising regularly and eating a healthy diet. But, Dr. Sindhura Bandaru, an ...

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...

Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with ...

An oral melanocortin-4 receptor agonist conferred significant BMI reductions among adolescents and adults with hypothalamic obesity, according to a presenter. As Healio previously reported, ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...

About 1 in 5 classified as overweight based on BMI alone considered to have obesity according to European society definition.

A new study reports that measurements that detect body fat are a more accurate predictor of mortality risk than body mass ...

Rhythm Pharmaceuticals’ push to move obesity patients from jabs to tabs has stayed on beat. | Rhythm Pharmaceuticals’ push to ...

Rhythm Pharmaceuticals' experimental drug helped patients with a rare form of obesity caused by brain damage cut weight in a small study, the drugmaker said on Monday, sending its shares 24% higher in ...